Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 52: 901-903, 2006; 10.1373/clinchem.2005.064816
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alapi, K.
Right arrow Articles by Maródi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alapi, K.
Right arrow Articles by Maródi, L.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2006;52:901-903.)
© 2006 American Association for Clinical Chemistry, Inc.


Letters to the Editor

Prenatal Diagnosis of the WAS R86H Sequence Variation in Heterozygous Twins

Krisztina Alapi1, Melinda Erdos1, Olga Török2 and László Maródi1,a

Departments of,1 Infectious and Pediatric Immunology, and, 2 Obstetrics and Gynecology, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary

aAddress correspondence to this author at: Department of Infectious and Pediatric Immunology, University of Debrecen, Medical and Health Science Center, H-4012 Debrecen, Hungary. Fax 36-52-430-323; e-mail lmarodi{at}jaguar.dote.hu.


To the Editor:

A healthy 28-year-old woman was heterozygous for the Wiskott–Aldrich syndrome gene (WAS) sequence variation, and the syndrome-causing variant was inherited by her first-born son (Fig. 1 ). The 2.5-year-old hemizygous boy developed characteristic features of the WAS, including eczema, thrombocytopenia, and recurrent infections of the lower respiratory tract from early infancy. The mother presented recently with a new pregnancy, and the abdominal ultrasound scan obtained at 7 weeks of gestation revealed that she had conceived twins. We counseled the mother on the complexity and risks of invasive prenatal diagnostic procedures and made it clear that the potential risk of disease in a male fetus is 50%; nevertheless, she decided to continue her pregnancy and to undergo invasive prenatal evaluation. At 11 weeks of gestation, chorionic villus sampling by a transabdominal approach was performed with no complications. Rapid karyotyping revealed a male and a female fetus. We then isolated genomic DNA from the chorionic villus samples and performed bidirectional DNA sequencing of the WAS gene. Neither of the fetuses carried the R86H WAS sequence variant found in the mother and her son (Fig. 1 ).


Figure 1
View larger version (60K):
[in this window]
[in a new window]
 
Figure 1. Pedigree and sequences of the WAS gene in the affected family.

The WAS sequence variant in the hemizygous patient was inherited from the healthy mother, who was heterozygous for the R86H variation. The dashed symbols represent the fetuses in the twin pregnancy.

The WAS is a rare X-linked immunodeficiency disorder characterized by eczema, thrombocytopenia with small platelets, recurrent pyogenic infections, and high incidences of autoimmune diseases and malignancies (1). The genetic basis of the disease is a sequence variant in the WAS gene encoding a 502–amino acid protein that is expressed in the cytosol of hematopoietic cells (2)(3). Sequence variations occur throughout the WAS gene and include missense, nonsense, and splice-site variants; insertions; and deletions (4). In a recent study, 141 unique sequence variations were identified in 265 patients affected with WAS or X-linked thrombocytopenia, including 4 R86H missense variants(4). The predominant WAS sequence variations were missense variants, which were typically located in exons 1 to 4.

Genomic medicine provided a powerful means to detect WAS sequence variations in this early pregnancy and to assist the mother in her decision-making on the fate of her fetuses. This report is the first to describe a case of DNA analysis in a twin pregnancy at risk for WAS. As in singleton pregnancies, chorionic villus sampling is also used as an invasive tool for early sex determination and DNA assays in multiple pregnancies (5). We decided to use chorionic villus sampling because it has considerable advantages over amniocentesis by offering rapid karyotyping and DNA studies at an early stage of pregnancy. In multifetal pregnancies, early diagnosis by chorionic villus sampling also facilitates selective termination of an affected fetus. Remarkably, fetal termination performed earlier in pregnancy may be associated with a higher survival rate of the unaffected twin (6). It is important to emphasize that only experienced centers should perform these procedures because of the technical challenges and the expertise needed.


References

  1. Snapper SB, Rosen FS. A family of WASPs. N Engl J Med 2003;348:350-351.[Free Full Text]
  2. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994;78:635-644.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  3. Ochs HD, Notarangelo LD. Structure and function of the Wiskott-Aldrich syndrome protein. Curr Opin Hematol 2005;12:284-291.[CrossRef][Medline] [Order article via Infotrieve]
  4. Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, et al. Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood 2004;104:4010-4019.[Abstract/Free Full Text]
  5. Weisz B, Rodeck CH. Invasive diagnostic procedures in twin pregnancies. Prenat Diagn 2005;25:751-758.[Medline] [Order article via Infotrieve]
  6. Evans MI, Goldberg JD, Horenstein J, Wapner RJ, Ayoub MA, Stone J, et al. Selective termination for structural, chromosomal and Mendelian anomalies: international experience. Am J Obstet Gynecol 1999;181:893-897.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alapi, K.
Right arrow Articles by Maródi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alapi, K.
Right arrow Articles by Maródi, L.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Endocrinology and Metabolism


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS